Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proliferating Cell Nuclear Antigen | 17 | 2016 | 31 | 3.030 |
Why?
|
DNA Repair | 12 | 2016 | 64 | 1.950 |
Why?
|
DNA Replication | 9 | 2020 | 34 | 1.550 |
Why?
|
DNA Repair-Deficiency Disorders | 3 | 2016 | 3 | 1.160 |
Why?
|
Mutation, Missense | 3 | 2016 | 50 | 1.130 |
Why?
|
Glaucoma | 3 | 2017 | 22 | 1.050 |
Why?
|
DNA-Directed DNA Polymerase | 8 | 2011 | 15 | 1.020 |
Why?
|
Trabeculectomy | 2 | 2019 | 3 | 0.770 |
Why?
|
DNA Damage | 12 | 2021 | 99 | 0.690 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2020 | 35 | 0.680 |
Why?
|
Ubiquitin | 6 | 2010 | 15 | 0.680 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2016 | 27 | 0.670 |
Why?
|
Cell Cycle Proteins | 6 | 2018 | 55 | 0.650 |
Why?
|
Saccharomyces cerevisiae | 5 | 2006 | 20 | 0.600 |
Why?
|
Ophthalmology | 1 | 2017 | 7 | 0.590 |
Why?
|
Mutant Proteins | 2 | 2014 | 14 | 0.580 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 12 | 0.570 |
Why?
|
Glaucoma, Open-Angle | 5 | 2019 | 22 | 0.560 |
Why?
|
Educational Measurement | 1 | 2017 | 123 | 0.560 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 127 | 0.550 |
Why?
|
DNA-Binding Proteins | 4 | 2018 | 147 | 0.530 |
Why?
|
Repressor Proteins | 1 | 2015 | 50 | 0.500 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2015 | 32 | 0.500 |
Why?
|
Chromatin | 5 | 2011 | 25 | 0.490 |
Why?
|
Cooperative Behavior | 1 | 2015 | 81 | 0.490 |
Why?
|
Clinical Competence | 1 | 2017 | 333 | 0.470 |
Why?
|
Patient Care Team | 1 | 2015 | 129 | 0.470 |
Why?
|
Humans | 42 | 2021 | 32115 | 0.460 |
Why?
|
Internship and Residency | 1 | 2017 | 313 | 0.440 |
Why?
|
Cell Cycle | 6 | 2008 | 77 | 0.440 |
Why?
|
Schizosaccharomyces | 2 | 2010 | 5 | 0.430 |
Why?
|
Radiation Tolerance | 2 | 2010 | 24 | 0.420 |
Why?
|
Antibody Formation | 3 | 2021 | 46 | 0.410 |
Why?
|
Fibroblasts | 4 | 2019 | 111 | 0.410 |
Why?
|
Chromosomal Instability | 3 | 2020 | 5 | 0.400 |
Why?
|
Needs Assessment | 1 | 2012 | 76 | 0.390 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2019 | 15 | 0.390 |
Why?
|
Health Services Needs and Demand | 1 | 2012 | 81 | 0.380 |
Why?
|
Immunization, Secondary | 2 | 2021 | 11 | 0.380 |
Why?
|
Intraocular Pressure | 5 | 2019 | 40 | 0.370 |
Why?
|
Cell Nucleus | 2 | 2009 | 108 | 0.350 |
Why?
|
Ovarian Neoplasms | 2 | 2020 | 96 | 0.330 |
Why?
|
Medical Records | 2 | 2009 | 76 | 0.320 |
Why?
|
Multiprotein Complexes | 2 | 2018 | 18 | 0.300 |
Why?
|
Family | 1 | 2007 | 117 | 0.280 |
Why?
|
Genomic Instability | 3 | 2020 | 6 | 0.280 |
Why?
|
Xenopus Proteins | 1 | 2006 | 1 | 0.280 |
Why?
|
Mutation | 8 | 2020 | 489 | 0.280 |
Why?
|
Female | 21 | 2021 | 20016 | 0.260 |
Why?
|
DNA Breaks | 1 | 2005 | 2 | 0.250 |
Why?
|
Antibodies, Neutralizing | 2 | 2021 | 19 | 0.240 |
Why?
|
DNA | 4 | 2018 | 226 | 0.230 |
Why?
|
Mitosis | 2 | 2020 | 25 | 0.220 |
Why?
|
Cell Line, Transformed | 2 | 2015 | 18 | 0.220 |
Why?
|
Adolescent | 8 | 2021 | 3569 | 0.210 |
Why?
|
Male | 16 | 2021 | 19218 | 0.210 |
Why?
|
Protein Binding | 4 | 2016 | 201 | 0.210 |
Why?
|
Models, Biological | 4 | 2020 | 392 | 0.210 |
Why?
|
Animals | 12 | 2020 | 7542 | 0.200 |
Why?
|
Young Adult | 6 | 2021 | 2666 | 0.200 |
Why?
|
Histones | 4 | 2019 | 53 | 0.200 |
Why?
|
Ultraviolet Rays | 3 | 2011 | 51 | 0.190 |
Why?
|
Middle Aged | 12 | 2021 | 11839 | 0.190 |
Why?
|
Aldehydes | 1 | 2021 | 5 | 0.190 |
Why?
|
Immunization Schedule | 1 | 2021 | 26 | 0.190 |
Why?
|
Carcinogens, Environmental | 1 | 2020 | 2 | 0.190 |
Why?
|
Aluminum | 1 | 2020 | 5 | 0.190 |
Why?
|
Cell Line | 8 | 2019 | 435 | 0.190 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 35 | 0.190 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 4 | 0.190 |
Why?
|
Centrosome | 1 | 2020 | 2 | 0.190 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2020 | 13 | 0.180 |
Why?
|
Ubiquitination | 3 | 2016 | 16 | 0.180 |
Why?
|
Binding Sites | 3 | 2016 | 130 | 0.180 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 8 | 0.180 |
Why?
|
T-Lymphocytes | 1 | 2020 | 124 | 0.180 |
Why?
|
Cytogenetic Analysis | 1 | 2019 | 17 | 0.170 |
Why?
|
Eye Infections, Bacterial | 1 | 2019 | 5 | 0.170 |
Why?
|
X Chromosome Inactivation | 1 | 2019 | 6 | 0.160 |
Why?
|
Endophthalmitis | 1 | 2019 | 8 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2018 | 2 | 0.160 |
Why?
|
Transcriptional Activation | 1 | 2019 | 42 | 0.160 |
Why?
|
Chromosomes, Human | 1 | 2018 | 10 | 0.160 |
Why?
|
Aneuploidy | 1 | 2018 | 10 | 0.160 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 23 | 0.160 |
Why?
|
Optic Disk | 3 | 2007 | 11 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2021 | 308 | 0.150 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 726 | 0.150 |
Why?
|
Zinc Fingers | 2 | 2016 | 9 | 0.150 |
Why?
|
DNA Methylation | 1 | 2019 | 141 | 0.150 |
Why?
|
Adult | 8 | 2021 | 9381 | 0.140 |
Why?
|
DNA Polymerase III | 1 | 2016 | 2 | 0.140 |
Why?
|
Cell Fusion | 1 | 2016 | 4 | 0.140 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2016 | 6 | 0.140 |
Why?
|
Mice | 6 | 2020 | 2484 | 0.140 |
Why?
|
Cytoplasm | 1 | 2016 | 29 | 0.140 |
Why?
|
Retinal Degeneration | 1 | 2016 | 17 | 0.140 |
Why?
|
Apoptosis | 1 | 2018 | 360 | 0.140 |
Why?
|
Aged | 7 | 2021 | 10314 | 0.140 |
Why?
|
Protein-Serine-Threonine Kinases | 2 | 2020 | 50 | 0.140 |
Why?
|
Aged, 80 and over | 4 | 2019 | 3990 | 0.140 |
Why?
|
Retina | 1 | 2016 | 61 | 0.140 |
Why?
|
Genetic Speciation | 1 | 2016 | 2 | 0.130 |
Why?
|
Hybridization, Genetic | 1 | 2016 | 3 | 0.130 |
Why?
|
Protein Engineering | 1 | 2016 | 19 | 0.130 |
Why?
|
Infertility | 1 | 2016 | 19 | 0.130 |
Why?
|
Institutional Management Teams | 1 | 2015 | 2 | 0.130 |
Why?
|
New Zealand | 1 | 2015 | 9 | 0.130 |
Why?
|
Health Care Coalitions | 1 | 2015 | 6 | 0.130 |
Why?
|
Australia | 1 | 2015 | 72 | 0.130 |
Why?
|
Reproducibility of Results | 1 | 2017 | 765 | 0.120 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2006 | 18 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 3 | 2010 | 105 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2020 | 765 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2019 | 780 | 0.110 |
Why?
|
Rosaceae | 1 | 2013 | 1 | 0.110 |
Why?
|
Schizosaccharomyces pombe Proteins | 2 | 2010 | 4 | 0.110 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2013 | 14 | 0.110 |
Why?
|
Protein Structure, Tertiary | 3 | 2016 | 99 | 0.110 |
Why?
|
Indonesia | 1 | 2012 | 8 | 0.100 |
Why?
|
Tonometry, Ocular | 1 | 2012 | 11 | 0.100 |
Why?
|
Tasmania | 2 | 2009 | 4 | 0.100 |
Why?
|
DNA Helicases | 1 | 2011 | 4 | 0.100 |
Why?
|
Blotting, Western | 3 | 2011 | 289 | 0.090 |
Why?
|
Incidence | 2 | 2019 | 1199 | 0.090 |
Why?
|
Single-Blind Method | 2 | 2021 | 203 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 767 | 0.090 |
Why?
|
Replication Protein A | 1 | 2009 | 1 | 0.090 |
Why?
|
Nuclear Proteins | 1 | 2010 | 75 | 0.090 |
Why?
|
Microscopy | 1 | 2009 | 26 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 68 | 0.090 |
Why?
|
Prevalence | 1 | 2012 | 989 | 0.080 |
Why?
|
Migraine Disorders | 1 | 2009 | 67 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2020 | 40 | 0.080 |
Why?
|
Nucleic Acid Conformation | 1 | 2008 | 48 | 0.080 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 608 | 0.070 |
Why?
|
Twins, Dizygotic | 1 | 2007 | 8 | 0.070 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 14 | 0.070 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2018 | 17 | 0.070 |
Why?
|
Quantitative Trait, Heritable | 1 | 2007 | 47 | 0.070 |
Why?
|
Alleles | 2 | 2019 | 248 | 0.070 |
Why?
|
Recombination, Genetic | 2 | 2016 | 22 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2006 | 19 | 0.070 |
Why?
|
Ubiquitins | 1 | 2006 | 2 | 0.070 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2005 | 8 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 78 | 0.070 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2005 | 38 | 0.060 |
Why?
|
Cisplatin | 1 | 2005 | 76 | 0.060 |
Why?
|
G2 Phase | 2 | 2020 | 17 | 0.060 |
Why?
|
Escherichia coli | 1 | 2005 | 87 | 0.060 |
Why?
|
Sepharose | 1 | 2004 | 6 | 0.060 |
Why?
|
Nickel | 1 | 2004 | 2 | 0.060 |
Why?
|
Chromatography, Gel | 1 | 2004 | 9 | 0.060 |
Why?
|
Vision Disorders | 2 | 2019 | 23 | 0.060 |
Why?
|
Epitopes | 1 | 2004 | 24 | 0.060 |
Why?
|
Chromatin Assembly Factor-1 | 1 | 2003 | 1 | 0.060 |
Why?
|
Point Mutation | 2 | 2019 | 28 | 0.060 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2004 | 81 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 104 | 0.060 |
Why?
|
Fungal Proteins | 1 | 2003 | 7 | 0.060 |
Why?
|
Cell Division | 1 | 2004 | 99 | 0.060 |
Why?
|
Molecular Chaperones | 1 | 2003 | 13 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 73 | 0.060 |
Why?
|
Heparin | 1 | 2004 | 73 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2003 | 26 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2009 | 766 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2003 | 136 | 0.050 |
Why?
|
Nucleosomes | 1 | 2002 | 4 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2020 | 3306 | 0.050 |
Why?
|
Models, Genetic | 1 | 2002 | 94 | 0.050 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2021 | 5 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 10 | 0.050 |
Why?
|
DNA Adducts | 1 | 2021 | 12 | 0.050 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2021 | 7 | 0.050 |
Why?
|
Genes, p53 | 1 | 2021 | 23 | 0.050 |
Why?
|
Metformin | 1 | 2021 | 22 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2020 | 17 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2020 | 12 | 0.050 |
Why?
|
Brazil | 1 | 2020 | 16 | 0.050 |
Why?
|
South Africa | 1 | 2020 | 11 | 0.050 |
Why?
|
Immunity, Cellular | 1 | 2020 | 20 | 0.050 |
Why?
|
Immunity, Humoral | 1 | 2020 | 13 | 0.050 |
Why?
|
Esophagus | 1 | 2021 | 22 | 0.050 |
Why?
|
Viral Load | 1 | 2021 | 70 | 0.050 |
Why?
|
Chromosome Segregation | 1 | 2020 | 3 | 0.050 |
Why?
|
Immunoglobulin M | 1 | 2020 | 17 | 0.050 |
Why?
|
Phthalazines | 1 | 2020 | 4 | 0.050 |
Why?
|
Protein Subunits | 1 | 2020 | 34 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 13 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2020 | 57 | 0.050 |
Why?
|
Microtubules | 1 | 2020 | 23 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 55 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2020 | 167 | 0.050 |
Why?
|
Pedigree | 2 | 2014 | 140 | 0.050 |
Why?
|
Piperazines | 1 | 2020 | 54 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 88 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2020 | 120 | 0.040 |
Why?
|
Histological Techniques | 1 | 2020 | 7 | 0.040 |
Why?
|
Karyotyping | 1 | 2020 | 29 | 0.040 |
Why?
|
Models, Molecular | 2 | 2014 | 193 | 0.040 |
Why?
|
RNA, Guide | 1 | 2019 | 3 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2019 | 11 | 0.040 |
Why?
|
Mutagenesis | 1 | 2019 | 33 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 91 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2019 | 40 | 0.040 |
Why?
|
Paclitaxel | 1 | 2020 | 67 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 82 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2020 | 525 | 0.040 |
Why?
|
Exfoliation Syndrome | 1 | 2019 | 2 | 0.040 |
Why?
|
Vaccination | 1 | 2020 | 138 | 0.040 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2019 | 3 | 0.040 |
Why?
|
Victoria | 1 | 2019 | 24 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 132 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 11 | 0.040 |
Why?
|
CpG Islands | 1 | 2019 | 45 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 633 | 0.040 |
Why?
|
Glycolysis | 1 | 2018 | 20 | 0.040 |
Why?
|
Exons | 1 | 2019 | 52 | 0.040 |
Why?
|
Bacteria | 1 | 2019 | 48 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2018 | 5 | 0.040 |
Why?
|
DNA, Single-Stranded | 1 | 2018 | 14 | 0.040 |
Why?
|
Phenotype | 2 | 2014 | 632 | 0.040 |
Why?
|
Gene Expression | 1 | 2020 | 338 | 0.040 |
Why?
|
Visual Acuity | 1 | 2019 | 73 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 322 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 510 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 171 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 71 | 0.040 |
Why?
|
Adenosine Triphosphatases | 2 | 2011 | 13 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2011 | 834 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2019 | 146 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2010 | 285 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2010 | 359 | 0.040 |
Why?
|
Integrases | 1 | 2016 | 2 | 0.040 |
Why?
|
X Chromosome | 1 | 2016 | 26 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2019 | 3510 | 0.040 |
Why?
|
Y Chromosome | 1 | 2016 | 43 | 0.030 |
Why?
|
Chromosome Pairing | 1 | 2016 | 1 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 324 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2016 | 13 | 0.030 |
Why?
|
Xeroderma Pigmentosum | 2 | 2005 | 2 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2016 | 264 | 0.030 |
Why?
|
Meiosis | 1 | 2016 | 33 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 3880 | 0.030 |
Why?
|
Time Factors | 1 | 2020 | 2151 | 0.030 |
Why?
|
Regeneration | 1 | 2016 | 170 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 682 | 0.030 |
Why?
|
Dwarfism | 1 | 2014 | 5 | 0.030 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2014 | 7 | 0.030 |
Why?
|
Aging, Premature | 1 | 2014 | 4 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2014 | 18 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2014 | 14 | 0.030 |
Why?
|
Photosensitivity Disorders | 1 | 2014 | 12 | 0.030 |
Why?
|
Telangiectasis | 1 | 2014 | 5 | 0.030 |
Why?
|
Homozygote | 1 | 2014 | 58 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 39 | 0.030 |
Why?
|
Child | 2 | 2014 | 2442 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 72 | 0.030 |
Why?
|
Syndrome | 1 | 2014 | 72 | 0.030 |
Why?
|
Hearing Loss | 1 | 2014 | 26 | 0.030 |
Why?
|
Cell Survival | 2 | 2005 | 285 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2014 | 247 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2009 | 1542 | 0.030 |
Why?
|
Patch Tests | 1 | 2013 | 8 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2016 | 1022 | 0.030 |
Why?
|
Neoplasms | 1 | 2019 | 728 | 0.030 |
Why?
|
Histone Deacetylase 1 | 1 | 2011 | 2 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 5 | 0.020 |
Why?
|
Acetylation | 1 | 2011 | 15 | 0.020 |
Why?
|
S Phase | 1 | 2011 | 15 | 0.020 |
Why?
|
Heterochromatin | 1 | 2011 | 12 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 43 | 0.020 |
Why?
|
Hela Cells | 1 | 2011 | 79 | 0.020 |
Why?
|
RNA Interference | 1 | 2011 | 76 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 263 | 0.020 |
Why?
|
Phosphorylation | 1 | 2011 | 229 | 0.020 |
Why?
|
Mutagens | 1 | 2010 | 3 | 0.020 |
Why?
|
Nuclear Localization Signals | 1 | 2010 | 4 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2010 | 60 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 71 | 0.020 |
Why?
|
Methyl Methanesulfonate | 1 | 2008 | 4 | 0.020 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2008 | 1 | 0.020 |
Why?
|
Anthraquinones | 1 | 2008 | 6 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 495 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 582 | 0.020 |
Why?
|
Visual Fields | 1 | 2006 | 27 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2006 | 1 | 0.020 |
Why?
|
Rad51 Recombinase | 1 | 2006 | 3 | 0.020 |
Why?
|
DNA, Fungal | 1 | 2006 | 2 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2006 | 23 | 0.020 |
Why?
|
Optic Nerve Diseases | 1 | 2006 | 19 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2005 | 8 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 24 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 20 | 0.020 |
Why?
|
DNA Polymerase beta | 1 | 2005 | 1 | 0.020 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2005 | 2 | 0.020 |
Why?
|
Protein Conformation | 1 | 2005 | 84 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 88 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 15 | 0.020 |
Why?
|
Lod Score | 1 | 2005 | 72 | 0.020 |
Why?
|
Glycoproteins | 1 | 2005 | 45 | 0.020 |
Why?
|
Eye Proteins | 1 | 2005 | 34 | 0.020 |
Why?
|
Computational Biology | 1 | 2005 | 91 | 0.020 |
Why?
|
Transfection | 1 | 2005 | 191 | 0.020 |
Why?
|
Genes, cdc | 1 | 2003 | 5 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 17 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 733 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2006 | 881 | 0.010 |
Why?
|